Collaboration - August 9, 2021
AstraZeneca and Regeneron collaborate
AstraZeneca has entered into a collaboration with Regeneron to research, develop and commercialize small molecule compounds directed against the GPR75 target with the potential to treat obesity and related co-morbidities. The companies will evenly split research and development costs and share equally in any future potential profits. “We are pleased to announce this important collaboration […]
Collaboration - July 8, 2021
Cyxone collaborate with the Medical University of Vienna
After identifying some valuable new potential treatments for T20K, Cyxone has entered into a research collaboration with Prof. Christian Gruber, the inventor of T20K & Prof Gernot Schabbauer from the Medical University of Vienna. The aim of the study is to deepen the understanding of the mode of action (MoA) of T20K and to explore […]
Collaboration - June 22, 2021
Orion to co-develop CAR T-cell cancer therapy
Orion Corporation and the Finnish Red Cross Blood Service have concluded an agreement on research collaboration with the aim of developing chimeric antigen receptor (CAR) T-cell therapy. The Blood Service has experience in cell research, in the supply of cord blood and stem cell grafts classified as tissue products, and in the preparation of ATMP […]
Collaboration - June 21, 2021
SAGA Diagnostics expands research collaboration
The company has announced an expanded research collaboration with Professor Charles Swanton, at the University College London (UCL) Cancer Institute. Last year, SAGA and UCL entered into a research collaboration on a limited number of patients. With the newly signed agreement, SAGA will utilize its SAGAsafe assays for detection of a panel of mutations in […]
Collaboration - June 16, 2021
Pilloxa enters new collaboration
Pilloxa has announced that it is to collaborate with the Nordic office of Chiesi Global Rare Diseases on using the company’s platform to support the treatment journey for patients with nephropathic cystinosis across Scandinavia. “We are honored to work with the Nordic office of Chiesi Global Rare Diseases to support patients, an incredible partner within […]
Collaboration - June 2, 2021
SciLifeLab enters new collaboration with EMBL
SciLifeLab and The European Molecular Biology Laboratory (EMBL) will intensify collaboration between the two organizations under the joint Memorandum of Understanding (MoU). The MoU declares a joint ambition to stimulate mutually beneficial scientific and academic exchange and collaboration in various areas of life science research in order to ensure greater connectivity, availability of scientific data, […]